Announcements Trials

Browse Landscape

Phase

Status

Completed 16 Recruiting 7 Unknown 6 Not yet recruiting 5 Terminated 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 20 Rectal Neoplasms 11 Colonic Neoplasms 9 Neoplasm Metastasis 7 Carcinoma, Hepatocellular 6 Pancreatic Neoplasms 5 Stomach Neoplasms 4 Recurrence 2 Esophageal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Peritoneal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Motor Activity 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Esophagogastric Cancer 1 Esophageal Squamous Cell Carcinoma 1 Clinical Stage I Gastric Cancer AJCC v8 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Borderline Resectable Pancreatic Adenocarcinoma 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

Gemcitabine 3 Cisplatin 3 Irinotecan 2 Fluorouracil 2 Capecitabine 2 tremelimumab 1 pamiparib 1 durvalumab 1 brigimadlin 1 atezolizumab 1 Temozolomide 1 Surgical Procedures, Operative 1 Paclitaxel 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 IMC-001 1 Blood Specimen Collection 1 ARX788 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Biliary Tract Neoplasms × Oxaliplatin × Clear all

NCT04796454 2022-06-01

PAMICC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡